346 related articles for article (PubMed ID: 18226083)
41. [Daptomycin: pharmacological characteristics and its role in the treatment of gram positive infections].
Araos R; García P; Chanqueo L; Labarca J
Rev Chilena Infectol; 2012 Apr; 29(2):127-31. PubMed ID: 22689024
[TBL] [Abstract][Full Text] [Related]
42. Structure-Activity Relationships of Daptomycin Lipopeptides.
Karas JA; Carter GP; Howden BP; Turner AM; Paulin OKA; Swarbrick JD; Baker MA; Li J; Velkov T
J Med Chem; 2020 Nov; 63(22):13266-13290. PubMed ID: 32687352
[TBL] [Abstract][Full Text] [Related]
43. Daptomycin: first in a new class of antibiotics for complicated skin and soft-tissue infections.
Kern WV
Int J Clin Pract; 2006 Mar; 60(3):370-8. PubMed ID: 16494659
[TBL] [Abstract][Full Text] [Related]
44. Current treatment options for community-acquired methicillin-resistant Staphylococcus aureus infection.
Moellering RC
Clin Infect Dis; 2008 Apr; 46(7):1032-7. PubMed ID: 18444820
[TBL] [Abstract][Full Text] [Related]
45. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
[TBL] [Abstract][Full Text] [Related]
46. Clinical experience with daptomycin: bacteraemia and endocarditis.
Levine DP
J Antimicrob Chemother; 2008 Nov; 62 Suppl 3():iii35-39. PubMed ID: 18829724
[TBL] [Abstract][Full Text] [Related]
47. Daptomycin.
Enoch DA; Bygott JM; Daly ML; Karas JA
J Infect; 2007 Sep; 55(3):205-13. PubMed ID: 17629567
[TBL] [Abstract][Full Text] [Related]
48. Treatment options for skin and soft tissue infections caused by meticillin-resistant Staphylococcus aureus:oralvs.parenteral; home vs. hospital.
Esposito S; Leone S; Petta E; Noviello S; Ianniello F
Int J Antimicrob Agents; 2009 Jul; 34 Suppl 1():S30-5. PubMed ID: 19560673
[TBL] [Abstract][Full Text] [Related]
49. Cefazolin therapy for Staphylococcus aureus bacteremia.
Fernández-Guerrero ML; de Górgolas M
Clin Infect Dis; 2005 Jul; 41(1):127. PubMed ID: 15937778
[No Abstract] [Full Text] [Related]
50. Characterization of a daptomycin-nonsusceptible vancomycin-intermediate Staphylococcus aureus strain in a patient with endocarditis.
Julian K; Kosowska-Shick K; Whitener C; Roos M; Labischinski H; Rubio A; Parent L; Ednie L; Koeth L; Bogdanovich T; Appelbaum PC
Antimicrob Agents Chemother; 2007 Sep; 51(9):3445-8. PubMed ID: 17620372
[TBL] [Abstract][Full Text] [Related]
51. Lack of evidence associating nephrotoxicity with low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis.
Bruss JB
Clin Infect Dis; 2009 Sep; 49(5):806; author reply 807-8. PubMed ID: 19653850
[No Abstract] [Full Text] [Related]
52. Vancomycin-Resistant Staphylococcus hemolyticus Bacteremia Treated Successfully by Intravenous Daptomycin and Catheter Removal in a Hemodialysis Patient.
Hung YM; Wang JH; Wann SR
Ther Apher Dial; 2015 Jun; 19(3):302. PubMed ID: 25530308
[No Abstract] [Full Text] [Related]
53. High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides.
Lichterfeld M; Ferraro MJ; Davis BT
Int J Antimicrob Agents; 2010 Jan; 35(1):96. PubMed ID: 19896341
[No Abstract] [Full Text] [Related]
54. Topical antibiotic treatment for uncomplicated skin and skin structure infections: review of the literature.
Pangilinan R; Tice A; Tillotson G
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):957-65. PubMed ID: 19803705
[TBL] [Abstract][Full Text] [Related]
55. [Treatment of mitral MRSA endocarditis using daptomycin].
Senneville E; Beltrand E; Legout L; Leroy O; Fayad G
Med Mal Infect; 2008 Dec; 38 Spec No 2():13-5. PubMed ID: 19185204
[No Abstract] [Full Text] [Related]
56. Future strategies for treating Staphylococcus aureus bloodstream infections.
Naber CK
Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():26-34. PubMed ID: 18226087
[TBL] [Abstract][Full Text] [Related]
57. Study of methicillin-resistant Staphylococcus aureus on the U.S./Mexico border.
Rivera JO; Ho H; Domínguez DC; Tyroch AH; Antony S; Norte A; Pérez-Ruvalcaba JA
Travel Med Infect Dis; 2009 Jan; 7(1):30-4. PubMed ID: 19174298
[TBL] [Abstract][Full Text] [Related]
58. Eosinophilic pneumonia induced by daptomycin.
Hayes D; Anstead MI; Kuhn RJ
J Infect; 2007 Apr; 54(4):e211-3. PubMed ID: 17207858
[TBL] [Abstract][Full Text] [Related]
59. Discordance between Staphylococcus aureus nasal colonization and skin infections in children.
Chen AE; Cantey JB; Carroll KC; Ross T; Speser S; Siberry GK
Pediatr Infect Dis J; 2009 Mar; 28(3):244-6. PubMed ID: 19165132
[TBL] [Abstract][Full Text] [Related]
60. [Conservative treatment of a hip prosthesis infection due to methicillin-resistant Staphylococcus aureus using prolonged antibiotic therapy based on linezolid followed by daptomycin].
Grossi O; Talarmin JP; Boutoille D; Frioux R; Corvec S; Raffi F
Med Mal Infect; 2008 Dec; 38 Spec No 2():10-2. PubMed ID: 19185203
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
